Villar-Martínez, María Dolores http://orcid.org/0000-0003-3920-0176
Puledda, Francesca http://orcid.org/0000-0002-1933-4049
Goadsby, Peter J. http://orcid.org/0000-0003-3260-5904
Funding for this research was provided by:
National Institute for Health Research
South London and Maudsley NHS Foundation Trust
Article History
Accepted: 2 November 2020
First Online: 23 November 2020
Compliance with Ethical Standards
:
: Maria Dolores Villar-Martinez has no disclosures. Francesca Puledda has received honoraria from Teva UK. Peter J Goadsby reports, over the last 36 months, grants and personal fees from Alder Biopharmaceuticals, Aeon Biopharma, Allergan, Biohaven Pharmaceuticals Inc., Clexio, Electrocore LLC, eNeura, Epalex, Impel Neuropharma, MundiPharma, Novartis, Pfizer, Santara Therapeutics, Teva Pharmaceuticals, Trigemina Inc., WL Gore, and personal fees from MedicoLegal work, Massachusetts Medical Society, Up-to-Date, Oxford University Press, and Wolters Kluwer; and a patent magnetic stimulation for headache assigned to eNeura without fee.
: The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care.